The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review
Abstract
Oxidative stress, manifested by protein oxidation, lipid peroxidation, DNA oxidation and 3-nitrotyrosine formation, among other indices, is observed in Alzheimer's disease (AD) brain. Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD. Our laboratory and others have implicated Abeta(1-42)-induced free radical oxidative stress in the neurodegeneration observed in AD brain. This paper reviews some of these studies from our laboratory. Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Abeta(1-42) was critical to its oxidative stress and neurotoxic properties. Because the C-terminal region of Abeta(1-42) is helical, and invoking the i + 4 rule of helices, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter. This interaction could alter the susceptibility for oxidation of Met-35, i.e. free radical formation. Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Abeta(1-42). Removal of the Met-35 residue from the lipid bilayer by substitution of the negatively charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Abeta(1-42). The free radical scavenger vitamin E prevented A(beta (1-42)-induced ROS formation, protein oxidation, lipid peroxidation, and neurotoxicity in hippocampal neurons, consistent with our model for Abeta-associated free radical oxidative stress induced neurodegeneration in AD. ApoE, allele 4, is a risk factor for AD. Synaptosomes from apoE knock-out mice are more vulnerable to Abeta-induced oxidative stress (protein oxidation, lipid peroxidation, and ROS generation) than are those from wild-type mice. We also studied synaptosomes from allele-specific human apoE knock-in mice. Brain membranes from human apoE4 mice have greater vulnerability to Abeta(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indices, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder. Using immunoprecipitation of proteins from AD and control brain obtained no longer than 4h PMI, selective oxidized proteins were identified in the AD brain. Creatine kinase (CK) and beta-actin have increased carbonyl groups, an index of protein oxidation, and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE). Abeta inhibits CK and causes lipid peroxidation, leading to HNE formation. Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD. Other oxidatively modified proteins have been identified in AD brain by proteomics analysis, and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degradation of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy production (alpha-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2). Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Abeta(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Abeta(1-42)-induced oxidative stress and neurodegeneration in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and mitochondrial dysfunction are prominent features of many neurodegenerative diseases including AD (Butterfield, 2002; Butterfield and Boyd-Kimball, 2018; Sharma and Kim, 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
In the citing paper
“For the same reason, the Aβ insertion into the lipid bilayer of the neuronal plasma membrane induces lipid peroxidation in a direct manner (Butterfield, 2002).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781
Cited by
Sorted by citations
Items 701–794 of 794
Neurosteroids in Oxidative Stress‐Mediated Injury in Alzheimer Disease
Grimm, A., Mensah‐Nyagan, A. G., & Eckert, A. (2011) · Wiley eBooks · doi:10.1002/9781118148143.ch8 · Cited by 1
Brain Iron Deposition in Aging and Disease: Role of HO-1
Schipper, H. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_7 · Cited by 1
Aging and Oxidized Proteins: Generation and Degradation
Goto, S., Takahashi, R., & Nakamoto, H. (2004) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.35.53 · Cited by 1
Rukhsana Sultana, A., Poon, H. F., & Butterfield, D. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_15 · Cited by 1
Butterfield, D. A., Rukhsana Sultana, A., & Poon, H. F. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch1 · Cited by 1
Metabolic Abnormalities in Alzheimer Disease
Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1
Rodriguez, P., Kalia, V., Gibson, C. L., Gichi, Z., Rajoo, A., Matier, C. D., Pezacki, A. T., Xiao, T., Carvelli, L., Chang, C. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570462 · Cited by 1
Blutbasierte Mikrozirkulationsmarker bei der Alzheimer-Demenz
Knauer, K. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12369
Protective Effects of Citrullus vulgaris on Irradiated Lymphocyte Submembrane
Osman, K., Md.Saad, N., Elias, E., Mohamed, J., Ibrahim, S. F., & Promwichit, P. (2005)
Developmental Lead Exposure, Epigentics and Late Onset Alzheimer's Disease
Zawia, N. H., & Basha, R. M. (2010) · doi:10.1002/9780470917060.ch9
Williams, T. I. (2005) · UKnowledge (University of Kentucky)
Wang, C., Pi, E., Zhan, Q., & Ngai, S. M. (2011) · InTech eBooks · doi:10.5772/22225
Gururaj Joshi, A. (2006) · UKnowledge (University of Kentucky)
Role of Oxidatively Stressed Lipids in Amyloid Formation and Toxicity
Axelsen, P. H., & Komatsu, H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch27
Poon, H. F. (2005) · UKnowledge (University of Kentucky)
Flavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology
Rezai-Zadeh, K. P. (2008) · Digital Commons - University of South Florida (University of South Florida)
Augé, C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003617456
17 Beta-Estradiol, Integrins, and Synaptic Proteins
Chandra, M. (2009) · ProQuest Demo Repository
Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease
Gao, K., Niu, M., Zhai, X., Huang, Y., Tian, X., & Li, T. (2014) · Genetika · doi:10.2298/gensr1402631g
SPECIFIC AMYLOID-BETA OLIGOMERS IN HUMAN CEREBROSPINAL FLUID
Handoko, M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
OXIDATS AD HUMADISEASES: ROLE OF ATIOXIDAT MEDICIAL PLATSA REVIEW.
Rajkapoor, B., Burkan, Z. E., & Raju, S. K. (2010)
Enfermedad de Alzheimer: una panorámica desde su primera descripción hacia una perspectiva molecular
García, S., Vázquez, R. M. C., Dávalos, E. G. M., Castillo, J. L., Silva, B. M., & Ortiz, A. D. J. V. (2009) · Medicina Interna de México
Pu, D. C. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3833qz0
Kirkwood, C. M. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Amyloid Beta Peptide Induces D-serine Dependent NMDAR Dysfunction in the Mouse Hippocampus
Wang, B. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-3953
Bartley, M. G. (2010) · Digital Commons - DU (University of Denver)
Tin, G. (2014) · UWSpace (University of Waterloo)
Vargas, A. P. (2012) · Americanae (AECID Library)
Growth Hormone and Insulin-Like Growth Factor-I in Alzheimer's Disease
Saez, J. M. G. (2012) · The Open Endocrinology Journal · doi:10.2174/1874216501206010080
Coordination of Metal Ions to β-Amyloid Peptide: Impact on Alzheimer’s Disease
Faller, P., Penna, G. L., Hureau, C., & Furlan, S. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0004
Immunotherapeutic Approaches for Alzheimer’s Disease
Bowers, W. J., & Federoff, H. J. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-12
Astrocyte–Neuronal Interactionand Oxidative Injury
Chock, V. Y., & Giffard, R. G. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch13
Verbandt, S., Henriques, S. T., Spincemaille, P., Harvey, P. J., Chandhok, G., Sauer, V., Coninck, B. D., Cassiman, D. M., Craik, D. J., Cammue, B. P. A., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.07.013
Micronutrients in Improvement of the Standard Therapy in Traumatic Brain Injury
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-13
Antyborzec, I. (2016) · Dublin City University Open Access Institutional Repository (Dublin City University)
Methylmercury and Alzheimer's Disease
Kintz, J. (2014)
Croft, C. L. (2016) · Research Portal (King's College London)
The Role of Glutathione Metabolism in the Neuroprotective Effect of Mood Stabilizers
Pasiliao, C. C. (2011) · TSpace (University of Toronto)
Phillips, E. C. (2017) · Research Portal (King's College London)
Molecular origins of tissue vulnerability to aberrant aggregation in protein misfolding diseases
Freer, R. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.22631
The Physiopathological Crossroads of Aging
Lasierra-Cirujeda, J., Coronel, P., Pascual-Salcedo, M. J. A., Gimeno, M., Salcedo, M. M. A. P., Lasierra-Ibañez, A., & AZA, C. L. (2019) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2019.76007
ZASTOSOWANIE HODOWLI IN VITRO KOMÓREK LUDZKICH W BADANIACH PESTYCYDÓW
Jabłońska‐Trypuć, A., Wołejko, E., Wydro, U., & Butarewicz, A. (2017) · Budownictwo i Inżynieria Środowiska · doi:10.24427/bis-2017-vol8-no1-0004
Dawson, R. (2019) · Research Explorer (The University of Manchester)
Cysteine in Alzheimer's Disease
Ingale, S. P., Patil, R., & Upaganlawar, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch013
Jackson, T. A., & Najem, M. S. (2012) · Digital WPI
Babušíková, E., Dobrota, Đ., Тернер, Э. Д., & Наливаева, Н. Н. (2021) · Биохимия · doi:10.31857/s0320972521060063
Polymeric drug delivery systems for mitigating oxidative stress
Ahlawat, J., & Narayan, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00018-8
Aβ Variants and Their Impact on Amyloid Formation and Alzheimer’s Disease Progression
Ötvös, L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_7
Behavioral Methods Used in the Study of Learning and Memory
Hall, F. S., & Saber, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_37 · Cited by 1
Rukhsana Sultana, A., & Butterfield, D. A. (2007) · Clinical Proteomics · doi:10.1002/9783527622153.ch23
El‐Sewify, I. M., Radwan, A. G., & Azzazy, H. M. E.-S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007919
Micronutrient Antioxidants, Cognition, and Neuropathology
Opii, W. O., & Head, E. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch5
Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration
Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_13
- Prospects and Potential Applications of Seaweeds as Neuroprotective Agents
(2013) · CRC Press eBooks · doi:10.1201/b13904-8
Khan, M. A. S., Morgan, M., Essa, M. M., Akbar, M. D., Guillemin, G. J., & Song, B. (2022) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_18_21
Targeting pathological changes in the gut protects the CNS from neuropathology.
Charpentier, B. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3966
Xiao, C., Chen, T., Yuan, M., Li, Y., & Wang, F. (2022) · Research Square · doi:10.21203/rs.3.rs-2224001/v1
Masumoto, S. (2022) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.60.137
Özkoç, M., Can, B., İlhan, A. O., Söğüt, İ., Ataızı, Z. S., Kandemir, T., Dönmez, D. B., & Kanbak, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3346277/v1
Morozov, А. V., Burov, A. V., Funikov, S. Y., Teterina, E. V., Astakhova, T. M., Erokhov, P. A., Ustyugov, A. A., & Карпов, В. Л. (2023) · Molecular Biology · doi:10.31857/s0026898423050142
Halim, M. A., Rosli, I. M., Jaafar, S. S. M., Ooi, H. M., Leong, P. W., Rosli, N., Shamsuddin, S., Najimudin, N., & Azzam, G. (2024) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2024.032.2.08
The biochemical pathways of Alzheimer's disease
El-Gammal, M. A., & Kodous, F. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00001-4
Mitochondrial and chloroplastic targeting peptides peptidase, PreP
Glaser, E. G., Kmiec, B., & Teixeira, P. F. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00274-5
Regulation of protein phosphatases in oxidatively stressed neurons
Ho, Y. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
Oxidative Stress and Pathophysiology of Chronic Disease
Balaji, S., Pandian, M. S., Ganesamoorthy, R., Parameswari, R., & Babujanarthanam, R. (2026) · Springer eBooks · doi:10.1007/978-981-96-9670-3_3 · Cited by 1
Contrastive Learning on Heterogeneous Graphs for Oligopeptide-Disease Prediction
Tan, D., Chen, J., Zhou, X., Su, Y., Wang, K., & Zheng, C. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356319
Debnath, B., Gazi, R., Deyashi, R., Muztaba, M., Ahmed, A. Y., & Dewan, D. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_24
Neuroprotective Marine Bioactives in Paediatric ADHD: A Focused Review on Therapeutic Potential
Chaudhary, B., Arya, P., Kumar, P., Agarwal, G., & Grewal, A. S. (2026) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273418458251114104948
Etude de l'interaction du TIMP-1 avec ses récepteurs
Verzeaux, L. (2015) · theses.fr (ABES) · doi:10.70675/02b3787dze0bbz4a18z9bd2zc42bb1e85844
Mitochondria, neurosteroids and biological rhythms : implications in health and disease states
Grimm, A. (2015) · theses.fr (ABES) · doi:10.70675/8aac5aa9z77cdz49bdz9cf5z0ff0b5dd0f84
Feat-Vetel, J. (2018) · theses.fr (ABES) · doi:10.70675/11b7a40fzb10ez43b4z85aez38d4b27bbb07
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Han, G.-E., Choi, H.-Y., Lee, G.-M., Kim, J.-E., Douangdeuane, B., & Leem, J.-Y. (2026) · 생약학회지 · doi:10.22889/kjp.2026.57.1.38
Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer’s Disease
Cambi, X., Liu, Z., Guo, K., & Xia, W. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093379
Katsuki, T., Kinno, A., Ida, T., Kasamatsu, S., Sumitani, H., & Ihara, H. (2026) · NFS Journal · doi:10.1016/j.nfs.2026.100273
Piplani, M., Thakur, S., Kumar, P., Garg, S. S., Goyal, A., & Goyal, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3483
Shim, S., Lee, Y., Lee, H., Lee, N., Kim, D. E., Han, J., Huh, K. M., Jung, H., & Yang, K. (2026) · Nano Convergence · doi:10.1186/s40580-026-00584-8
Hossan, R., Selim, S., Rakib, I. H., Sayeed, M. A., Chakrabarty, A., Hossain, M. A., Mia, E., Debnath, D., Bristy, A. H., & Hasan, M. S. A. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72507
Newman, S. F. (2009) · UKnowledge (University of Kentucky)
Metadata
- Authors
- Allan Butterfield, D.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 12
- Pages
- 1307-1313
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2153767421
- Cited by
- 786
- References
- 58
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 30 · 2017: 32 · 2016: 45 · 2015: 43 · 2014: 42 · 2013: 39 · 2012: 42
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institute on Aging (P01AG010836, P01AG005119, AG 10836, AG12423, AG0 5119, R01AG012423)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid beta peptide 1-42, oxidative stress, neurotoxicity, Alzheimer's disease, protein oxidation, lipid peroxidation, nitrotyrosine, vitamin E, hippocampal neurons, synaptosomes, apolipoprotein E, APOE ε4, amyloid fibril formation, neurodegeneration, lipid bilayers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Humans, Lipid Bilayers, Methionine, Molecular Sequence Data, Neurons, Peptide Fragments, Peptides, Free Radical Scavengers, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Structure, Tertiary, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review